Cargando…
Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694412/ https://www.ncbi.nlm.nih.gov/pubmed/33246477 http://dx.doi.org/10.1186/s12939-020-01323-z |
_version_ | 1783614971493482496 |
---|---|
author | Ding, L. Jidkova, S. Greuter, M. J. W. Van Herck, K. Goossens, M. Martens, P. de Bock, G. H. Van Hal, G. |
author_facet | Ding, L. Jidkova, S. Greuter, M. J. W. Van Herck, K. Goossens, M. Martens, P. de Bock, G. H. Van Hal, G. |
author_sort | Ding, L. |
collection | PubMed |
description | BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening coverage for both screening strategies are yet unknown. OBJECTIVE: To assess the determinants of BC screening coverage in Flanders. METHODS: Reimbursement data were used to attribute a screening status to each woman in the target population for the years 2008–2016. Yearly coverage data were categorized as screening inside or outside BCSP or no screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the determinants of screening type. RESULTS: Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40% (IQR: 41.50–54.40%) and 14.10% (IQR: 9.80–19.80%) respectively. A higher coverage rate outside BSCP was statistically significantly (P < 0.001) associated with more crowded households (OR: 3.797, 95% CI: 3.199–4.508), younger age, higher population densities (OR: 2.528, 95% CI: 2.455–2.606), a lower proportion of unemployed job seekers (OR: 0.641, 95% CI: 0.624–0.658) and lower use of dental care (OR: 0.969, 95% CI: 0.967–0.972). CONCLUSION: Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP. |
format | Online Article Text |
id | pubmed-7694412 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76944122020-11-30 Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade Ding, L. Jidkova, S. Greuter, M. J. W. Van Herck, K. Goossens, M. Martens, P. de Bock, G. H. Van Hal, G. Int J Equity Health Research BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening coverage for both screening strategies are yet unknown. OBJECTIVE: To assess the determinants of BC screening coverage in Flanders. METHODS: Reimbursement data were used to attribute a screening status to each woman in the target population for the years 2008–2016. Yearly coverage data were categorized as screening inside or outside BCSP or no screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the determinants of screening type. RESULTS: Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40% (IQR: 41.50–54.40%) and 14.10% (IQR: 9.80–19.80%) respectively. A higher coverage rate outside BSCP was statistically significantly (P < 0.001) associated with more crowded households (OR: 3.797, 95% CI: 3.199–4.508), younger age, higher population densities (OR: 2.528, 95% CI: 2.455–2.606), a lower proportion of unemployed job seekers (OR: 0.641, 95% CI: 0.624–0.658) and lower use of dental care (OR: 0.969, 95% CI: 0.967–0.972). CONCLUSION: Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP. BioMed Central 2020-11-27 /pmc/articles/PMC7694412/ /pubmed/33246477 http://dx.doi.org/10.1186/s12939-020-01323-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ding, L. Jidkova, S. Greuter, M. J. W. Van Herck, K. Goossens, M. Martens, P. de Bock, G. H. Van Hal, G. Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title | Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title_full | Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title_fullStr | Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title_full_unstemmed | Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title_short | Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade |
title_sort | coverage determinants of breast cancer screening in flanders: an evaluation of the past decade |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694412/ https://www.ncbi.nlm.nih.gov/pubmed/33246477 http://dx.doi.org/10.1186/s12939-020-01323-z |
work_keys_str_mv | AT dingl coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT jidkovas coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT greutermjw coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT vanherckk coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT goossensm coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT martensp coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT debockgh coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade AT vanhalg coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade |